
CMS Boosts Sickle Cell Gene Therapy Access
A Paradigm Shift: CMS Unlocks Gene Therapy Access for Sickle Cell Disease It’s not every day you see a policy move that fundamentally alters the landscape of chronic disease management, but that’s precisely what the […]